Phagocytic cells metabolize 25-hydroxyvitamin D3 to 10-oxo-19-nor-25-hydroxyvitamin D3 and a new metabolite, 8 alpha,25-dihydroxy-9,10-seco-4,6,10(19)-cholestatrien-3-one.
The metabolism of 25-hydroxyvitamin D3 [25(OH)D3] was examined in several phagocytic cells including alveolar macrophages and myeloid leukemia cells (M1, HL-60 and U937). Phagocytic cells converted 25(OH)D3 to 10-oxo-19-nor-25-hydroxyvitamin D3 and a new metabolite. The former metabolite was dominant in shorter incubation periods (1 h), whereas the latter dominated over longer incubation periods (24 h). The new metabolite was produced from 25(OH)D3 directly but not through 10-oxo-19-nor-25-hydroxyvitamin D3. The new metabolite was unequivocally identified as 8 alpha,25-dihydroxy-9-10-seco-4,6,10(19)-cholestatrien-3-one. These results suggest that phagocytic cells somehow promote oxidation of the triene part of vitamin D compounds.
D000818:Animals; D002112:Calcifediol / Q000031:analogs & derivatives* / Q000378:metabolism*; D002782:Cholestenes / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D007700:Kinetics; D008264:Macrophages / Q000378:metabolism; D008297:Male; D051379:Mice; D010586:Phagocytes / Q000378:metabolism*; D011650:Pulmonary Alveoli / Q000166:cytology
D002782:Cholestenes; C053021:8,25-dihydroxy-9,10-seco-4,6,10(19)-cholestatrien-3-one; C039030:19-nor-10-keto-25-hydroxyvitamin D3; D002112:Calcifediol